Showing results (1-10 of 84) with videos related to
Sort By:
Pageof 9
Clinical Genitourinary Cancer|February 21, 2026
Patient-Reported Outcomes and Long-Term Toxicity in stage I TGCT: A Retrospective Single-Center Cohort (1994-2023)Patricia Capdevila, Jorge AparicioClinical Genitourinary Cancer|December 12, 2025
Second Malignancies and Non-Cancer Mortality in Long-Term Survivors of Stage I Testicular Cancer: A 30-Year Institutional Experience and Literature ReviewPatricia Capdevila, Jorge AparicioClinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|October 13, 2025
Epidemiological patterns, temporal trends in management and long-term outcomes in testicular cancer: a 30-year single center experiencePatricia Capdevila, Jorge Aparicio UrtasunJournal of Medical Case Reports|November 16, 2024
Carboplatin-induced hematuria in a patient with stage I seminoma: a case reportPatricia Capdevila, Cristobal Carrasco, Jorge AparicioClinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 17, 2026
Risk-adapted management in stage I testicular germ-cell tumors: long-term outcomes from a single-center cohort (1994-2023)Patricia Capdevila, Cristobal Carrasco, Saturnino Luján, et al.Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|April 30, 2025
Long-term survival and prognostic factors in extragonadal germ cell tumors: a 30-year experience at a single institutionPatricia Capdevila, Cristobal Carrasco, Elisa Gómez, et al.Expert Review of Anticancer Therapy|July 22, 2010
Management options for stage I seminomaJorge Aparicio, Roberto DíazMedical Oncology (Northwood, London, England)|October 5, 2006
Treatment of stage I testicular germ-cell tumorsJorge Aparicio, J R GermàTherapeutic Advances in Medical Oncology|June 26, 2026
Real-world outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel and prognostic factors in advanced pancreatic cancer: a retrospective cohort studyCarlos Escriva-Aranda, Eduardo Giner-Moreno, Emilio Soria Hernández, et al.Medical Oncology (Northwood, London, England)|April 26, 2017
Controversies in the multimodality management of locally advanced rectal cancerRobert Díaz Beveridge, Dilara Akhoundova, Gema Bruixola, et al.Pageof 9